Author details

Full Name

Janet K Cheetham

Affiliation

Foundation Fighting Blindness

ORCID

Career Start Year

1986

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36764426	Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.	Am J Ophthalmol	2023
37294701	Overcoming the Challenges to Clinical Development of X-Linked Retinitis Pigmentosa Therapies: Proceedings of an Expert Panel.	Transl Vis Sci Technol	2023
36690461	The Importance of Natural History Studies in Inherited Retinal Diseases.	Cold Spring Harb Perspect Med	2023
35293952	The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene.	Invest Ophthalmol Vis Sci	2022
36007554	Baseline Microperimetry and OCT in the RUSH2A Study: Structure-Function Association and Correlation With Disease Severity.	Am J Ophthalmol	2022
35266249	Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.	Hum Mutat	2022
34331386	Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).	Am J Med Genet A	2021
34004001	Tackling the Challenges of Product Development Through a Collaborative Rare Disease Network: The Foundation Fighting Blindness Consortium.	Transl Vis Sci Technol	2021
32327137	Re: Shen etÂ al.: Natural history of autosomal recessive Stargardt disease in untreated eyes: a systematic review and meta-analysis of study and individual level data (Ophthalmology. 2019;126:1288-1296).	Ophthalmology	2020
33133772	The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at Baseline.	Transl Vis Sci Technol	2020
32446738	Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.	Am J Ophthalmol	2020
31019847	A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned.	Transl Vis Sci Technol	2019
31259091	Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt Disease.	Transl Vis Sci Technol	2019
30412448	Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration.	J Ocul Pharmacol Ther	2018
29902293	Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10.	JAMA Ophthalmol	2018
28549516	Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.	Ophthalmology	2017
31047445	Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.	Ophthalmol Retina	2017
28702674	Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.	Invest Ophthalmol Vis Sci	2017
16117698	Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.	J Ocul Pharmacol Ther	2005
15016561	Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.	Surv Ophthalmol	2004
15313287	Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.	J Cataract Refract Surg	2004
11158809	Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.	Ophthalmology	2001
11448321	Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.	Arch Ophthalmol	2001
10088733	Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.	Am J Ophthalmol	1999
10363737	Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.	Clin Ther	1999
9888075	Efficacy and safety of nonpreserved ketorolac ophthalmic solution in postoperative ocular pain following radial keratotomy.	J Cataract Refract Surg	1999
8733853	Intraocular availability and pupillary effect of flurbiprofen and indomethacin during cataract surgery.	J Cataract Refract Surg	1996
8794707	Effect of topical anti-inflammatory treatment on the outcome of laser trabeculoplasty. The Fluorometholone-Laser Trabeculoplasty Study Group.	Am J Ophthalmol	1996
7722912	Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: functional vision and contrast sensitivity.	J Cataract Refract Surg	1995
8044980	Ocufen (flurbiprofen) in the treatment of ocular pain after radial keratotomy.	CLAO J	1994
8133476	Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin.	J Cataract Refract Surg	1994
2817661	Ideal concentration of tropicamide with hydroxyamphetamine 1% for routine pupillary dilation.	Ann Ophthalmol	1989
3502173	Reduction of inflammation following cataract surgery by the nonsteroidal anti-inflammatory drug, flurbiprofen.	Ophthalmic Surg	1987
3307591	Prednisolone acetate-gentamicin combination following cataract surgery.	Ann Ophthalmol	1987
3740174	The ocular hypertensive effect of 0.25% fluorometholone in corticosteroid responders.	Am J Ophthalmol	1986

1 - 35 of 35

Tarkan Mumcuoglu

Ankara Guven Hospital

Career Start Year 2005

Number of shared co-authors 1

Malik Y Kahook

University of Colorado School of Medicine

Career Start Year 2005

Number of shared co-authors 1

Wen Xing

Moorfields Eye Hospital NHS Foundation Trust

Career Start Year 2003

Number of shared co-authors 2

Jay M Stewart

University of California san francisco

Career Start Year 2002

Number of shared co-authors 2

Rishi P Singh

Cleveland Clinic Martin Hospitals, Cleveland Clinic Florida

Career Start Year 2000

Number of shared co-authors 4

Lingyun Cheng

Shiley Eye Institute, University of California San Diego

Career Start Year 1998

Number of shared co-authors 0

Jost Hillenkamp

University Hospital Wurzburg

Career Start Year 1998

Number of shared co-authors 1

Zvia Burgansky-Eliash

Goldschleger Eye Institute, Sheba Medical Center

Career Start Year 1997

Number of shared co-authors 1

Catey Bunce

Royal Marsden NHS Foundation Trust

Career Start Year 1997

Number of shared co-authors 2

Philip P Chen

University of Washington

Career Start Year 1995

Number of shared co-authors 0

Judy E Kim

Medical College of Wisconsin

Career Start Year 1994

Number of shared co-authors 7

Richard J Antcliff

Royal United Hospital Bath NHS Trust

Career Start Year 1994

Number of shared co-authors 1

JoAnn A Giaconi

University of California los angeles

Career Start Year 1994

Number of shared co-authors 0

Timothy W Olsen

Mayo Clinic

Career Start Year 1993

Number of shared co-authors 3

Quan Dong Nguyen

Byers Eye Institute, Stanford University

Career Start Year 1990

Number of shared co-authors 4

Susan Vitale

Division of Epidemiology and Clinical Applications, National Eye Institute

Career Start Year 1989

Number of shared co-authors 4

David S Greenfield

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine

Career Start Year 1989

Number of shared co-authors 2

Jeffrey M Liebmann

Edward S. Harkness Eye Institute, Columbia University Medical Center

Career Start Year 1989

Number of shared co-authors 1

Michael W Stewart

Mayo Clinic

Career Start Year 1988

Number of shared co-authors 0

James D Brandt

University of California davis

Career Start Year 1987

Number of shared co-authors 0

Marc D de Smet

MicroInvasive Ocular Surgery Clinic

Career Start Year 1987

Number of shared co-authors 2

Mary G Lynch

The Eye Clinic, Atlanta VA Medical Center

Career Start Year 1986

Number of shared co-authors 0

William J Feuer

From the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine

Career Start Year 1986

Number of shared co-authors 7

Robert J Noecker

Yale School of Medicine

Career Start Year 1985

Number of shared co-authors 1

Ronald P Danis

University of Wisconsin, Wisconsin EyeKor Inc.

Career Start Year 1981

Number of shared co-authors 9

Richard K Parrish

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine

Career Start Year 1980

Number of shared co-authors 1

Robert N Weinreb

Shiley Eye Institute, University of California San Diego

Career Start Year 1979

Number of shared co-authors 2

Thomas R Friberg

University of Pittsburgh

Career Start Year 1977

Number of shared co-authors 5

Leslie J Katz

Glaukos Corporation

Career Start Year 1977

Number of shared co-authors 0

Robert Ritch

Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai

Career Start Year 1969

Number of shared co-authors 2

row(s) 1 - 30 of 30

Jacque L Duncan

University of California san francisco

Co-authored papers 9

Todd A Durham

Foundation Fighting Blindness

Co-authored papers 9

Mark E Pennesi

Casey Eye Institute at Oregon Health & Science University (OHSU)

Co-authored papers 8

Michel Michaelides

Institute of Ophthalmology, University College London

Co-authored papers 8

David G Birch

Retina Foundation of the Southwest

Co-authored papers 8

Maureen G Maguire

Perelman School of Medicine, University of Pennsylvania

Co-authored papers 7

Hendrik P N Scholl

Institute of Molecular and Clinical Ophthalmology Basel

Co-authored papers 6

Sheila K West

Wilmer Eye Institute, Johns Hopkins University (S.W.

Co-authored papers 6

Frederick L Ferris

National Eye Institute, National Institutes of Health

Co-authored papers 5

Carel B Hoyng

Radboud University Medical Center

Co-authored papers 4

Katarina Stingl

University Eye Hospital, University of Tubingen

Co-authored papers 4

Artur V Cideciyan

Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania

Co-authored papers 3

Peiyao Cheng

Jaeb Center for Health Research (P.C.

Co-authored papers 3

Abigail T Fahim

University of Michigan (A.T.F.) ann arbor

Co-authored papers 3

Christina Y Weng

Cullen Eye Institute, Baylor College of Medicine

Co-authored papers 3

Eleonora M Lad

Duke University Medical Center

Co-authored papers 2

Joseph Carroll

Medical College of Wisconsin Eye Institute

Co-authored papers 2

Sina Farsiu

Duke University

Co-authored papers 2

Carmen C Brewer

Co-authored papers 2

Jos??-Alain Sahel

Co-authored papers 1

H Ishikawa

Mie University School of Medicine, NYU School of Medicine, New York Medical College, New York University School of Medicine, Oregon Health & Science University, Tufts University School of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh School of Mediine

Co-authored papers 1

Michele Melia

Jaeb Center for Health Research

Co-authored papers 1

Paul S Bernstein

University of Utah

Co-authored papers 1

SriniVas R Sadda

Doheny Eye Institute, University of California Los Angeles

Co-authored papers 1

Allison A Ayala

Jaeb Center for Health Research (P.C.